Boston Scientific bulks up peripheral artery device offering
This article was originally published in Clinica
Executive Summary
Boston Scientific is to boost its portfolio of devices for lower extremity peripheral artery disease by purchasing ReVascular Therapeutics, a privately-owned specialist in treating arterial occlusion.